Cita APA

Esposito, I., Marciano, S., & Trinks, J. (2018). Pharmacokinetic and pharmacodynamic evaluation of daclatasvir, asunaprevir plus beclabuvir as a fixed-dose co-formulation for the treatment of hepatitis C. Web

Citación estilo Chicago

Esposito, Isabella, Sebastian Marciano, and Julieta Trinks. Pharmacokinetic and Pharmacodynamic Evaluation of Daclatasvir, Asunaprevir Plus Beclabuvir As a Fixed-dose Co-formulation for the Treatment of Hepatitis C. 2018.

Cita MLA

Esposito, Isabella, Sebastian Marciano, and Julieta Trinks. Pharmacokinetic and Pharmacodynamic Evaluation of Daclatasvir, Asunaprevir Plus Beclabuvir As a Fixed-dose Co-formulation for the Treatment of Hepatitis C. 2018.